Search by Drug Name or NDC

    NDC 50742-0350-01 Metolazone 5 mg/1 Details

    Metolazone 5 mg/1

    Metolazone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ingenus Pharmaceuticals LLC. The primary component is METOLAZONE.

    Product Information

    NDC 50742-0350
    Product ID 50742-350_c6151f4b-35b7-4098-aa40-271c4386c5cd
    Associated GPIs
    GCN Sequence Number 008218
    GCN Sequence Number Description metolazone TABLET 5 MG ORAL
    HIC3 R1F
    HIC3 Description THIAZIDE AND RELATED DIURETICS
    GCN 34992
    HICL Sequence Number 003663
    HICL Sequence Number Description METOLAZONE
    Brand/Generic Generic
    Proprietary Name Metolazone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Metolazone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name METOLAZONE
    Labeler Name Ingenus Pharmaceuticals LLC
    Pharmaceutical Class Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215616
    Listing Certified Through 2024-12-31

    Package

    NDC 50742-0350-01 (50742035001)

    NDC Package Code 50742-350-01
    Billing NDC 50742035001
    Package 100 TABLET in 1 BOTTLE (50742-350-01)
    Marketing Start Date 2023-01-24
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.28455
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description METOLAZONE 5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis